Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy

Area of Science:

• Biotechnology
• Molecular Biology
• Immunology

Background:

• Clinical success in stem cell gene therapy (SCGT) for primary immunodeficiencies hinges on successful engraftment of genetically modified cells.
• Accurate assessment of transgene integration across all hematopoietic lineages is crucial for evaluating SCGT efficacy.

Purpose of the Study:

• To establish and validate a single cell-based droplet digital PCR (sc-ddPCR) method for precise quantification of transgene-positive cells.
• To analyze the distribution and engraftment levels of vector-transduced cells in patients with severe combined immunodeficiency (SCID) undergoing SCGT.

Main Methods:

• Development of a single cell-based droplet digital PCR (sc-ddPCR) technique involving single-cell encapsulation and emulsion PCR with transgene-specific primers and probes.
• Application of sc-ddPCR to analyze hematopoietic cell populations from SCID patients post-SCGT.

Main Results:

• The sc-ddPCR method successfully determined the ratio of transgene-positive cells at the genomic level.
• In SCID patients, engraftment of transduced cells was primarily observed in the T-cell lineage in peripheral blood.
• A small fraction of CD34+ cells in bone marrow showed vector integration, suggesting differentiation from limited stem or progenitor cells.

Conclusions:

• sc-ddPCR provides a simplified and powerful tool for detailed assessment of transgene-positive cell distribution in SCGT recipients.
• The findings highlight the importance of lineage-specific engraftment analysis in evaluating SCGT outcomes.